Mineralys Therapeutics, Inc. Common Stock (MLYS)
US$ 14.04-0.85%
Price Chart
Key Statistics
Market Cap
$ 1.05B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
329.45K
52W High
$ 18.38
52W Low
$ 8.24
Dividend Yield
0.00%
Beta
-0.31
Technicals
50-Day MA
14.4502
200-Day MA
12.4579
52 Week High
18.38
52 Week Low
8.241
About MLYS
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.
Employees
51
Headquarters
Radnor, PA
CEO
Mr. Jon Congleton
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg